Näytä suppeat kuvailutiedot

dc.contributor.authorViinikainen, Jutta
dc.contributor.authorBöckerman, Petri
dc.contributor.authorWillage, Barton
dc.contributor.authorElovainio, Marko
dc.contributor.authorKari, Jaana T.
dc.contributor.authorLehtimäki, Terho
dc.contributor.authorPehkonen, Jaakko
dc.contributor.authorPitkänen, Niina
dc.contributor.authorRaitakari, Olli
dc.contributor.editorTsima Billy Morara
dc.date.accessioned2024-03-06T08:47:33Z
dc.date.available2024-03-06T08:47:33Z
dc.date.issued2024
dc.identifier.citationViinikainen, J., Böckerman, P., Willage, B., Elovainio, M., Kari, J. T., Lehtimäki, T., Pehkonen, J., Pitkänen, N., & Raitakari, O. (2024). Effect of weight on depression using multiple genetic instruments. <i>PLoS ONE</i>, <i>19</i>(2), Article e0297594. <a href="https://doi.org/10.1371/journal.pone.0297594" target="_blank">https://doi.org/10.1371/journal.pone.0297594</a>
dc.identifier.otherCONVID_207414607
dc.identifier.urihttps://jyx.jyu.fi/handle/123456789/93821
dc.description.abstractA striking global health development over the past few decades has been the increasing prevalence of overweight and obesity. At the same time, depression has become increasingly common in almost all high-income countries. We investigated whether body weight, measured by body mass index (BMI), has a causal effect on depression symptoms in Finland. Using data drawn from the Cardiovascular Risk in Young Finns Study (N = 1,523, mean age 41.9, SD 5), we used linear regression to establish the relationship between BMI and depression symptoms measured by 21-item Beck’s Depression Inventory. To identify causal relationships, we used the Mendelian randomization (MR) method with weighted sums of genetic markers (single nucleotide polymorphisms, SNPs) as instruments for BMI. We employ instruments (polygenic risk scores, PGSs) with varying number of SNPs that are associated with BMI to evaluate the sensitivity of our results to instrument strength. Based on linear regressions, higher BMI was associated with a higher prevalence of depression symptoms among females (b = 0.238, p = 0.000) and males (b = 0.117, p = 0.019). However, the MR results imply that the positive link applies only to females (b = 0.302, p = 0.007) but not to males (b = -0.070, p = 0.520). Poor instrument strength may explain why many previous studies that have utilized genetic instruments have been unable to identify a statistically significant link between BMI and depression-related traits. Although the number of genetic markers in the instrument had only a minor effect on the point estimates, the standard errors were much smaller when more powerful instruments were employed.en
dc.format.mimetypeapplication/pdf
dc.language.isoeng
dc.publisherPublic Library of Science (PLoS)
dc.relation.ispartofseriesPLoS ONE
dc.rightsCC BY 4.0
dc.subject.otherFinland
dc.subject.otherbody weight
dc.subject.otherdepression
dc.subject.othersingle nucleotide polymorphisms
dc.subject.othermental health and psychiatry
dc.subject.othergenetics
dc.subject.othercardiovascular disease risk
dc.subject.otherbody mass index
dc.titleEffect of weight on depression using multiple genetic instruments
dc.typearticle
dc.identifier.urnURN:NBN:fi:jyu-202403062287
dc.contributor.laitosKauppakorkeakoulufi
dc.contributor.laitosSchool of Business and Economicsen
dc.type.urihttp://purl.org/eprint/type/JournalArticle
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1
dc.description.reviewstatuspeerReviewed
dc.relation.issn1932-6203
dc.relation.numberinseries2
dc.relation.volume19
dc.type.versionpublishedVersion
dc.rights.copyright© 2024 the Authors
dc.rights.accesslevelopenAccessfi
dc.subject.ysoperinnöllisyys
dc.subject.ysopsykiatria
dc.subject.ysosydän- ja verisuonitaudit
dc.subject.ysopainoindeksi
dc.subject.ysoperinnöllisyystiede
dc.subject.ysomasennus
dc.subject.ysomielenterveys
dc.format.contentfulltext
jyx.subject.urihttp://www.yso.fi/onto/yso/p9514
jyx.subject.urihttp://www.yso.fi/onto/yso/p4372
jyx.subject.urihttp://www.yso.fi/onto/yso/p9886
jyx.subject.urihttp://www.yso.fi/onto/yso/p21142
jyx.subject.urihttp://www.yso.fi/onto/yso/p5147
jyx.subject.urihttp://www.yso.fi/onto/yso/p7995
jyx.subject.urihttp://www.yso.fi/onto/yso/p1949
dc.rights.urlhttps://creativecommons.org/licenses/by/4.0/
dc.relation.doi10.1371/journal.pone.0297594
jyx.fundinginformationThe Young Finns Study has been financially supported by the Academy of Finland: grant numbers 356405, 322098, 286284, 134309 (Eye), 126925, 121584, 124282, 129378 (Salve), 117787 (Gendi), and 41071 (Skidi); the Social Insurance Institution of Finland; Competitive State Research Financing of the Expert Responsibility area of Kuopio; Tampere and Turku University Hospitals (grant number X51001); Juho Vainio Foundation; Paavo Nurmi Foundation; Finnish Foundation for Cardiovascular Research; Finnish Cultural Foundation; Sigrid Juselius Foundation; Tampere Tuberculosis Foundation; Emil Aaltonen Foundation; Yrjö Jahnsson Foundation; Signe and Ane Gyllenberg Foundation; Jenny and Antti Wihuri Foundation; Diabetes Research Foundation of Finnish Diabetes Association; EU Horizon 2020 (grant 755320 for TAXINOMISIS and grant 848146 for To Aition); European Research Council (grant number 742927 for MULTIEPIGEN project); Tampere University Hospital Supporting Foundation; Society of Finnish Clinical Chemistry; Cancer Foundation Finland; BETTER4U (Preventing obesity through Biologically and bEhaviorally Tailored inTERventions for you; project number: 101080117); Jane and Aatos Erkko Foundation. The use of linked data was supported by Palkansaajasäätiö and OP Group Research Foundation. ME was supported by the Academy of Finland (339390).
dc.type.okmA1


Aineistoon kuuluvat tiedostot

Thumbnail

Aineisto kuuluu seuraaviin kokoelmiin

Näytä suppeat kuvailutiedot

CC BY 4.0
Ellei muuten mainita, aineiston lisenssi on CC BY 4.0